Orthofix Medical (OFIX) Gross Profit (2016 - 2026)
Orthofix Medical has reported Gross Profit over the past 17 years, most recently at $139.5 million for Q1 2026.
- For the quarter ending Q1 2026, Gross Profit rose 14.74% year-over-year to $139.5 million, compared with a TTM value of $583.9 million through Mar 2026, up 8.09%, and an annual FY2025 reading of $566.0 million, up 3.69% over the prior year.
- Gross Profit came in at $139.5 million for Q1 2026, down from $156.3 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $156.3 million in Q4 2025 to a low of $78.1 million in Q1 2022.
- Median Gross Profit over the past 5 years was $127.2 million (2024), compared with a mean of $122.1 million.
- The sharpest move saw Gross Profit decreased 7.97% in 2022, then surged 53.21% in 2023.
- Over 5 years, Gross Profit stood at $89.2 million in 2022, then skyrocketed by 53.21% to $136.6 million in 2023, then rose by 8.94% to $148.8 million in 2024, then rose by 5.04% to $156.3 million in 2025, then decreased by 10.74% to $139.5 million in 2026.
- Per Business Quant, the three most recent readings for OFIX's Gross Profit are $139.5 million (Q1 2026), $156.3 million (Q4 2025), and $148.5 million (Q3 2025).